| 000 | 01832 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518044918.0 | ||
| 264 | 0 | _c20191017 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gutjnl-2018-317539 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Groof, E Joline | |
| 245 | 0 | 0 |
_aCost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial. _h[electronic resource] |
| 260 |
_bGut _c10 2019 |
||
| 300 |
_a1774-1780 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCecum _xsurgery |
| 650 | 0 | 4 |
_aColectomy _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCrohn Disease _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xeconomics |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIleitis _xdiagnosis |
| 650 | 0 | 4 |
_aIleum _xsurgery |
| 650 | 0 | 4 |
_aInfliximab _xeconomics |
| 650 | 0 | 4 |
_aLaparoscopy _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aStevens, Toer W | |
| 700 | 1 | _aEshuis, Emma J | |
| 700 | 1 | _aGardenbroek, Tjibbe J | |
| 700 | 1 | _aBosmans, Judith E | |
| 700 | 1 | _avan Dongen, J M | |
| 700 | 1 | _aMol, Bregje | |
| 700 | 1 | _aBuskens, Christianne J | |
| 700 | 1 | _aStokkers, Pieter C F | |
| 700 | 1 | _aHart, Ailsa | |
| 700 | 1 | _aD'Haens, Geert R | |
| 700 | 1 | _aBemelman, Willem A | |
| 700 | 1 | _aPonsioen, Cyriel Y | |
| 773 | 0 |
_tGut _gvol. 68 _gno. 10 _gp. 1774-1780 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gutjnl-2018-317539 _zAvailable from publisher's website |
| 999 |
_c29830180 _d29830180 |
||